MY NAVCARE PATIENT SUPPORT Trademark
MY NAVCARE PATIENT SUPPORT is a USPTO trademark filed by Genmab A/S. Status: Registered.
Trademark Facts
| Mark | MY NAVCARE PATIENT SUPPORT |
|---|---|
| Serial Number | 97936670 |
| Registration Number | 7819910 |
| Status | Registered |
| Filing Date | 2023-05-15 |
| Registration Date | 2025-06-03 |
| Mark Type | Combined |
| Nice Classes | 035 (Advertising & Business), 036 (Financial Services), 041 (Education & Entertainment), 044 (Medical Services), 045 (Legal Services) |
| Owner | Genmab A/S |
| Attorney of Record | Max Vern |
| Prosecution Events | 46 |
| Latest Event | R.PR on 2025-06-03 |
Goods & Services
Financial administration of patient reimbursement and patient financial assistance programs, namely reimbursement payment processing in the field of pharmaceutical and medical claims; Charitable services, namely, providing financial support to disadvantaged patients for the purpose of reimbursing medical and pharmaceutical expenses; Providing counseling and consulting in the field of healthcare insurance benefits in connection with patient reimbursement and patient financial assistance programs; Providing information about healthcare insurance plans, patient financial assistance, and patient reimbursement programs; Healthcare insurance services, namely, insurance eligibility review and verification, consultation and information in connection with patient reimbursement and patient financial assistance programs; Providing a database featuring information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical treatments; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries; Provision of consumer information in the field of patient reimbursement and medical benefit support; Business administrative services for medical referrals in connection to patient reimbursement programs; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries; Providing personal support services for patients and families of patients in connection to disease management and navigation through medical treatments, namely, emotional counseling and emotional support; Providing personal support services for families of patients with life threatening disorders in connection to disease management and reimbursement of medical expenses, namely, companionship, help with medical forms, emotional counseling and emotional support; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries; Medical assistance, namely disease management programs; provision of health care information in connection to disease management and navigation through medical treatments; provision of medical information in connection with health conditions and treatment of these conditions; medical counseling for patients in connection with disease management; Consultancy in the field of the medical treatment of cancer, autoimmune diseases, and inflammatory disorders; providing information to patients and families of patients in the field of administering medication and choosing treatments; providing a website featuring information in the medical and health fields in connection to disease management and navigation through medical treatments; health care services, namely disease management programs; medical and pharmaceutical consultation in connection to disease management; medical services, namely, provision of medical information for supporting patients in relation to the reimbursement of medical expenses; Providing a web site featuring medical information for patients in relation to the reimbursement of medical expenses; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries; "PATIENT SUPPORT"